In the current study, we evaluated ENG/CD105 expression, DNA methylation, immune response, and CD regulation, which could act as diagnostic, prognostic, and therapeutic markers of breast cancer (BC) including BRCA. This evidence concerns the gene ENG and breast carcinoma.